IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial
暂无分享,去创建一个
R. Horne | A. Copas | A. Story | I. Abubakar | H. Stagg | M. Lipman | F. Wurie | Nicole Vidal | H. Kunst | K. Kielmann | C. Campbell | M. Mandelbaum | M. Darvell | E. Pickett
[1] John L. Johnson,et al. A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis , 2018, Nature Medicine.
[2] H. Dongmei,et al. Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial , 2018, Trials.
[3] Z. Mor,et al. Risk Factors for Recurrent Tuberculosis among Successfully Treated Patients in Israel, 1999-2011. , 2017, The Israel Medical Association journal : IMAJ.
[4] G. Cooke,et al. Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008-2014. , 2017, The Journal of infection.
[5] V. Sequera,et al. How do we measure adherence to anti-tuberculosis treatment? , 2017, Expert review of anti-infective therapy.
[6] Sebastian Bonhoeffer,et al. The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB , 2016, PLoS Comput. Biol..
[7] M. Bonnet,et al. Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia. , 2015, The Journal of infectious diseases.
[8] N. Gale,et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research , 2013, BMC Medical Research Methodology.
[9] F. Cobelens,et al. Adherence to Tuberculosis Treatment, Sputum Smear Conversion and Mortality: A Retrospective Cohort Study in 48 Rwandan Clinics , 2013, PloS one.
[10] M. T. Gler,et al. Patterns of Treatment Interruption among Patients with Multidrug-Resistant TB (MDR TB) and Association with Interim and Final Treatment Outcomes , 2013, PloS one.
[11] P. Nyasulu,et al. Levels of Tuberculosis Treatment Adherence among Sputum Smear Positive Pulmonary Tuberculosis Patients Attending Care at Zomba Central Hospital, Southern Malawi, 2007–2008 , 2013, PloS one.
[12] Jeffrey K Aronson,et al. A new taxonomy for describing and defining adherence to medications. , 2012, British journal of clinical pharmacology.
[13] G. Kibiki,et al. The complexity of the adherence‐response relationship in tuberculosis treatment: why are we still in the dark and how can we get out? , 2011, Tropical medicine & international health : TM & IH.
[14] S. Michie,et al. The behaviour change wheel: A new method for characterising and designing behaviour change interventions , 2011, Implementation science : IS.
[15] G. Bonsel,et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.
[16] M. Blaxter,et al. Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background. , 2011, The Journal of infection.
[17] Sonya S. Shin,et al. Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment. , 2010, American journal of respiratory and critical care medicine.
[18] Elizabeth Broadbent,et al. The brief illness perception questionnaire. , 2006, Journal of psychosomatic research.
[19] B. Löwe,et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.
[20] Chandrasekaran,et al. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[21] S. De Geest,et al. Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.
[22] A. Hayward,et al. Risk factors for drug resistant tuberculosis in Leicestershire – poor adherence to treatment remains an important cause of resistance , 2003, Epidemiology and Infection.
[23] R. Spitzer,et al. The PHQ-9 , 2001, Journal of General Internal Medicine.
[24] Jeffrey N. Martin,et al. The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA , 1996, The Lancet.
[25] R. J. Hayes,et al. Cluster randomised trials, second edition , 2017 .
[26] B. Giraudeau,et al. [Cluster randomised trials]. , 2014, Annales de dermatologie et de venereologie.
[27] Nick Barber,et al. Concordance , adherence and compliance in medicine taking Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation , 2010 .
[28] Nick Barber,et al. Concordabe, adherence and Compliance in Medicine Taking , 2005 .
[29] J. Weinman,et al. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication , 1999 .